Navigation Links
Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
Date:5/23/2008

In response to the announcement by the Federal Aviation Administration (FAA), Commit Lozenges now offered to pilots and air traffic controllers

who are quitting smoking

PITTSBURGH, May 23 /PRNewswire/ -- With the Federal Aviation Administration's (FAA) recent announcement to remove a prescription anti-smoking pill from their approved list of safe medications for pilots, GSK Consumer Healthcare, an industry leader in smoking cessation, is offering one free 48 count of 2mg or 4mg Commit Cherry lozenges to all licensed commercial and private pilots who are interested in quitting smoking today, through June 30. It is important for pilots to understand that NRT has been the recommended aid for pilots to quit smoking since 1994, and that the FAA news in no way includes GSK's products, which are deemed safe and effective medicines to relieve nicotine withdrawal symptoms that arise during a quit attempt.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/gsk/33419/

Recent clinical research has demonstrated that the Commit 4 mg lozenge reverses the negative impact that nicotine withdrawal has on the ability to concentrate, attention deficit, short-term memory and selective attention during a quit attempt(1) -- all these issues were at the core of the FAA's ruling.

"It's important that pilots interested in quitting have access to safe, evidence-based treatments," said Bill Slivka, vice president, Smoking Control, GlaxoSmithKline Consumer Healthcare. "Over the past ten years, our NRT products, including the Commit lozenge, have helped more than 6.5 million smokers around the world quit. This free offer to pilots and air traffic controllers further demonstrates our mission to help more smokers achieve their goal of safely becoming smoke-free."

The Commit lozenge give-away program is open to all U.S. residents,
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ire-USNewswire/ -- The American Public Health Asso...s provisions in the health reform bill passed last...ill, the House takes important steps toward univer...ms and moving our health system from one that focu...eping people healthy," said Georges C. Benjamin, M...
(Date:11/8/2009)...romotes self-assurance, research finds , ...may have been right when she told you to sit up st...uld make you feel more confident about your though...straight gives a good impression to other people,"...ology professor at Ohio State University, said in ...
(Date:11/8/2009)...of the game later, doctors say , , SUNDA...e talk of the NFL this season, sidelining such sta...lie Parker. , Officials at the American Podiatr...iatric Sports Medicine are warning athletes to tak...ke football and lacrosse. , "Many fall sports a...
(Date:11/8/2009)...e-USNewswire/ -- Speaker Nancy Pelosi and Democrat...ouse passage of H.R. 3962, the Affordable Health C... 220 to 215. Below are the Speaker,s opening rema...ived a call from the President of the United State...ory for the American people. I thank the President...
(Date:11/8/2009)...called "Preventing and Healing AIDS Through O...ws that AIDS is a result of multiple, repeated and... system stressor agents, which can be either chemi...nal. , Oakland, CA (PRWE..., cell biologists, physicians, chemists and other ...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Good Posture May Inspire Confidence 2Health News:Rx for Fall Foot Injuries 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3
... 22 Bertalan Mesko, medical blogger and health 2....rst medical web 2.0 guidance service, launched N...aining all the web tools from quality blogs and co...gs, news aggregators, wikis, forums and social med...
...rships with AmeriCares and Clorox result in quick ...wildfires, tornadoes, flooding this spring , , CH...mpany have partnered to provide bleach and cleanin...re beginning the arduous task of cleaning out thei...
...lable in French . , A discovery made by resear... Davis Research Institute for Medical Research at ... for the early diagnosis and treatment of Alzheime...fellows Hamid Qureshi and Yifan Lu, report that th...
...22 A woman may share genetics with her mother, bu...unpleasant menopause filled with hot flashes, inso...Solutions: Vibrant Health, Balanced Living magazi...(HRT), which increases risk of breast cancer, stro...
... anti-tumor drugs is a hot research area. Chrysin ...ted flavonoid, has been reported to have many diff...anti-virus, antidiabetogenic activity and clear an...tion. To improve the biological activity of chrysi...
...n that you can personalize. , , PITTSBURGH, May 2...vider of Computerized Maintenance Management Syste...MS OnSite Professional, a CMMS you can personalize... create their own screen layouts or designs allowi...
Other Medicine News:Health News:Feeding America Partner Support Expedites Disaster Relief and Recovery Efforts 2Health News:Alzheimer's discovery could bring early diagnosis, treatment closer 2Health News:What You Need to Know in Your 40s to Have a Healthy Menopause -- Without Hormone Replacement Therapy 2Health News:A potential drug for liver carcinoma 2Health News:Four Rivers Software System Launches TMS OnSite Professional 2
(Date:11/6/2009)... 6 Boston Scientific Cor... reached an agreement in principle with the U.S. D...sories issued by its Guidant subsidiary in 2005. ...or to Boston Scientific,s 2006 acquisition of Guid...sed an investigation by the U.S. Attorney,s Office...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Keryx Biopharmaceuticals, ...on Tuesday, November 10, 2009 at 8:30 a.m. EST to ...nd business outlook for the remainder of 2009. Ro... will host the call. Keryx will announce its fina...o be issued prior to the call. ,, In order to p...
(Date:11/6/2009)...Newswire-FirstCall/ -- Caraco Pharmaceutical Labor...rolac tromethamine ophthalmic solution, 0.5% follo...ministration (FDA) for Sun Pharma,s Abbreviated Ne... opthalmic solution on the first day following pat...apeutically equivalent to Acular® Ophthalmic ...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 1Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 2Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 3Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 4Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 5Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 6Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 7Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 8UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 1UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 2CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 1CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 2
...mistry analysis, often conducted in a physicians o...on of a wide array of ailments; UTIs, diabetes, se... and kidney diseases. The estimated global market...llion per year and is growing strongly. For such a...nt clinical procedure, the manufacturers of urinal...
...amonte Content Editor Medcompare.com ,Accor...UNAIDS (Joint United Nations Programme on HIV/AIDS... people living with HIV globally reached an estima... 3 million deaths caused by AIDS. The latest data...ver one million people in the United States are no...
Other Medicine Technology:Urinalysis Analyzers: Large Capabilities in Every Size Device 2Urinalysis Analyzers: Large Capabilities in Every Size Device 3Rapid HIV Testing Increases Possibility of Treatment 2Rapid HIV Testing Increases Possibility of Treatment 3
...id Medication Delivery., ,Designed for adolescent...tes an additional lumen and injection port for rap...s three endotracheal tubes designs which allow for... delivery without additional adaptors., ETCO2&trad...
SHERIDAN LTS Endotracheal Tubes
SPIRAL-FLEX® Oral Precut Reinforced Tubes
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes
Medicine Products: